| International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease DC Fajgenbaum, TS Uldrick, A Bagg, D Frank, D Wu, G Srkalovic, ... Blood, The Journal of the American Society of Hematology 129 (12), 1646-1657, 2017 | 494 | 2017 |
| Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor JA Bridge, M Kanamori, Z Ma, D Pickering, DA Hill, W Lydiatt, MY Lui, ... The American journal of pathology 159 (2), 411-415, 2001 | 388 | 2001 |
| Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study KH Young, K Leroy, MB Møller, GWB Colleoni, M Sánchez-Beato, ... Blood, The Journal of the American Society of Hematology 112 (8), 3088-3098, 2008 | 257 | 2008 |
| ATIC-ALK: a novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv (2)(p23q35) GWB Colleoni, JA Bridge, B Garicochea, J Liu, DA Filippa, M Ladanyi The American journal of pathology 156 (3), 781-789, 2000 | 212 | 2000 |
| Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients VCC Andrade, AL Vettore, RS Felix, MSS Almeida, F de Carvalho, ... Cancer immunity 8 (1), 2008 | 191 | 2008 |
| Psychosocial adaptation and quality of life among Brazilian patients with different hematological malignancies FRM Santos, EH Kozasa, LF Maria de Lourdes, GWB Colleoni, JR Leite Journal of psychosomatic Research 60 (5), 505-511, 2006 | 104 | 2006 |
| FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4+ T regulatory cells WMT Braga, BR da Silva, AC de Carvalho, YH Maekawa, AB Bortoluzzo, ... Cancer Immunology, Immunotherapy 63, 1189-1197, 2014 | 83 | 2014 |
| The role of regulatory T cells and TH17 cells in multiple myeloma WMT Braga, D Atanackovic, GWB Colleoni Journal of Immunology Research 2012, 2012 | 83 | 2012 |
| Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6) HJ Cho, OL Caballero, S Gnjatic, VC C Andrade, GW Colleoni, AL Vettore, ... Cancer immunity 6 (1), 2006 | 71 | 2006 |
| Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma VTM Hungria, A Maiolino, G Martinez, GWB Colleoni, EODM Coelho, ... Haematologica 93 (5), 791-792, 2008 | 68 | 2008 |
| TGFβR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma F De Carvalho, GWB Colleoni, MS Sampaio Almeida, AL Carvalho, ... International journal of cancer 125 (8), 1985-1991, 2009 | 65 | 2009 |
| SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis RS Felix, GWB Colleoni, OL Caballero, M Yamamoto, MSS Almeida, ... Cancer letters 278 (1), 41-48, 2009 | 64 | 2009 |
| Frequency and prognostic relevance of cancer testis antigen 45 expression in multiple myeloma VCC Andrade, AL Vettore, MRR Silva, RS Felix, MSS Almeida, ... Experimental hematology 37 (4), 446-449, 2009 | 62 | 2009 |
| Observational study of multiple myeloma in Latin America VTM Hungria, A Maiolino, G Martinez, GO Duarte, R Bittencourt, L Peters, ... Annals of hematology 96, 65-72, 2017 | 56 | 2017 |
| Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: An overview of systematic reviews with meta-analyses. SS Aguiar PM, de Mendonça Lima T, Colleoni GWB Crit Rev Oncol Hematol 113, 195-212., 2017 | 53 | 2017 |
| Detection and Possible Prognostic Relevance of p53 Gene Mutations in Diffuse Large B-cell Lymphoma. An Analysis of 51 Cases and Review of the Literature FR Kerbauy, GWB Colleoni, STO Saad, MR Regis Silva, A Correa Alves, ... Leukemia & lymphoma 45 (10), 2071-2078, 2004 | 53 | 2004 |
| Primary breast lymphoma: an uncommon but curable disease RF Pinheiro, GWB Colleoni, OCG Baiocchi, FR Kerbauy, LCC Duarte, ... Leukemia & lymphoma 44 (1), 149-151, 2003 | 52 | 2003 |
| Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma C Ribas, GWB Colleoni, MRR Silva, MJ Carregoza, JO Bordin European journal of haematology 73 (5), 311-317, 2004 | 51 | 2004 |
| Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapy F de Carvalho, AL Vettore, GWB Colleoni Journal of Immunology Research 2012, 2012 | 47 | 2012 |
| Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for JAK/STAT pathway inhibition in myeloma patients MB de Oliveira, VL Fook-Alves, AIP Eugenio, RC Fernando, LFG Sanson, ... Cancer Letters 403, 206-215, 2017 | 43 | 2017 |
Marco A. ZagoUniversidade de São Paulo, USPE-mail confirmado em usp.br
